[New Hire Announcement] Welcome Firoz Jaipuri to Pin Therapeutics as a Director of Platform Chemistry
(주) 핀테라퓨틱스 2022.06.02
Pin Therapeutics is pleased to announce that Dr. Firoz Jaipuri is starting his role at Pin Therapeutics, Director of Platform Chemistry, from June 1st, 2022.
Here is the welcoming introduction from Nick Terrett, Head of Chemistry and Senior Advisor.
"'Pin Therapeutics are very pleased to welcome Dr. Firoz Jaipuri as Director, Platform Chemistry. Firoz has a PhD in Organic Chemistry from Iowa State University and followed this with postdoctoral experience at the Broad Institute. He has extensive experience in medicinal chemistry and drug discovery having worked for several companies including NewLink Genetics, Ideaya Biosciences, and Nura Bio. During his time at NewLink Genetics, Firoz led a program that resulted in the discovery of NLG-0919 (GDC-0919), a potent and ive IDO inhibitor that was progressed into human clinical trials and was out-licensed to Genentech. In his new role as Director of Platform Chemistry, Firoz will be able to rapidly advance Pin Therapeutics' work in discovering novel ligands for therapeutically relevant E3 ligases.'
Pin Therapeutics Inc.